Australian public assessment for Romidepsin
The safety of pralatrexate was evaluated in 111 peripheral T-cell lymphoma (PTCL) patients in one single-arm pivotal clinical study, PDX-008, in which patients received 30 mg/m2 once weekly for 6 weeks in 7-week cycles. The median duration of treatment was 70 days, with a range of 1 - 696 days. ................
................
To fulfill the demand for quickly locating and searching documents.
It is intelligent file search solution for home and business.
Related searches
- grammar assessment for high school
- assessment for english language proficie
- risk assessment for p2p payments
- assessment for english language proficiency
- english language assessment for adults
- free assessment for first grade
- career assessment for college students
- best assessment for esl students
- assessment for learning vs assessment of learning
- australian culture facts for kids
- australian fun facts for kids
- australian animals facts for kids